FDAClass IIJanuary 8, 2014

Niacin Extended Release Tablets recall

Niacin Extended Release Tablets, USP, 500 mg, 90 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., Sellersville, PA, 18960, NDC 0093-7392-98

Why was Niacin Extended Release Tablets recalled?

Failed Tablet/Capsule Specifications: There is a potential for broken tablets.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot#: 32900349B, Exp: 12/2014

Product
Niacin Extended Release Tablets, USP, 500 mg, 90 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., Sellersville, PA, 18960, NDC 0093-7392-98
Recalling firm
Teva Pharmaceuticals USA
Quantity
10,512 bottles
Distribution
Nationwide and Puerto Rico, American Samoa, Virgin Islands, and Canal Zone
Recall date
January 8, 2014
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls